← FDA DRUG APPROVALS

FDA ANDA · ANDA090102

RANITIDINE HYDROCHLORIDE

Sponsor: TORRENT

APPLICATION
ANDA090102
TYPE
ANDA
ORIGINAL APPROVAL
2009-05-26
LATEST ACTION
2010-04-30
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

RANITIDINE HYDROCHLORIDEDiscontinued
RANITIDINE HYDROCHLORIDE EQ 15MG BASE/ML · SYRUP · ORAL

Approval history

2010-04-30Labeling · Supplement 2AP
2009-05-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →